Theralase Technologies Inc. V.TLT

I wonder if the market

[Oden6570]

Realize the upside of our tech. I mean Canada's main lab for virus research assisting and leading research to develop vaccine for the whole family of covid and other viruses This company has become much more valuable IMHO.

[99942Apophis]

Oden6570 wrote Realize the upside of our tech. I mean Canada's main lab for virus research assisting and leading research to develop vaccine for the whole family of covid and other viruses This company has become much more valuable IMHO. True enough Oden6570, it is baffling, my thoughts are maybe once media and stock analysts bring it to the forefront and its viewed as an incredible solution

[StevenBirch]

Correct, we "the few" do know it's capabilities and are emotionally attached to it but I think for this to catch fire we just need some results - updates on those that have been treated and additional enrollment numbers for starters - and they should come soon. I think the last 2 announcements have put a rock solid floor under the stock but when we get good results I think they will

[CancerSlayer]

  Hey SB...I'm pretty full too, but this is turning into a buffet & there's always room for a little more dessert.  I plan to gorge a little on each new set of promising results (preclinical &/or clinical), especially when they're coming in from potentially "multiple" delicious indications.  Your feeling "morbidly obese" is another'

[StevenBirch]

Fat and jolly works for me!

[Rumpl3StiltSkin]

To Thors original question, No! They(markets) still need to connect the dots. TLT deserves a speculative rating, especially with all that is known over the last 3 weeks, above $1. We have 'on good authority' that TLT is still under major consideration for that 2nd Lumeda phase 1 trial. They are now working with Canadas national lab on a Covid 19 vaccine/therapy. Li Ka Shing Institute has

[Oilminerdeluxe]

I'll let him know.

[Rumpl3StiltSkin]

When the data from this Covid effort come in later this year, and more data from the Cancer fronts, who knows what the spec value will/should/ be....?

[99942Apophis]

Rumpl3StiltSkin wrote When the data from this Covid effort come in later this year, and more data from the Cancer fronts, who knows what the spec value will/should/ be....? Ok Rumpl3StiltSkin on speculation should we get hard numbers and what most people on this board think my wild guess falls into a wide range between 15 and 19 dollars that is with a high multiple awarded for the future PE

[Rumpl3StiltSkin]

I actually think that the Covid angle could get us to those valuations first, mostly on spec. 1433 could be the 6th or 7th Vaccine to get approved. It will be first amongst it's peers though in that it will also be an effective therapy and will not need any updates for future strains. It's only downside is it probably doesn't confer t-cell immunity, but I'm not sure about that.

[CancerSlayer]

  I'd be shocked if Roswell/Lumeda don't incorporate TLD-1433.  The question is, which news will we hear first imo....animal data or a new trial using TLD-1433?  Will be hard to hold this sp down much longer with so many coals in this fire.  I also hope our new public/private collaboration re: vaccine development isn't too unidimensional from a scientific

[2for1split]

You have to think that lab would be prioritzing best candidates for their work as well, considering the enormity of the situation. Lots of positives here.